236 related articles for article (PubMed ID: 24356667)
1. Pharmacological approach to diabetic macular edema.
Bandello F; Casalino G; Loewenstein A; Goldstein M; Pelayes D; Battaglia Parodi M
Ophthalmic Res; 2014; 51(2):88-95. PubMed ID: 24356667
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
Soheilian M; Ramezani A; Obudi A; Bijanzadeh B; Salehipour M; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Peyman GA
Ophthalmology; 2009 Jun; 116(6):1142-50. PubMed ID: 19376585
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological treatment for diabetic macular edema].
Fukumoto M; Ikeda T
Nihon Rinsho; 2015 Mar; 73(3):484-8. PubMed ID: 25812378
[TBL] [Abstract][Full Text] [Related]
4. Current intravitreal pharmacologic therapies for diabetic macular edema.
Colucciello M
Postgrad Med; 2015 Aug; 127(6):640-53. PubMed ID: 26036708
[TBL] [Abstract][Full Text] [Related]
5. Steroids as part of combination treatment: the future for the management of macular edema?
Bandello F; Battaglia Parodi M; Tremolada G; Lattanzio R; De Benedetto U; Iacono P
Ophthalmologica; 2010; 224 Suppl 1():41-5. PubMed ID: 20714180
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.
Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA
Retina; 2007; 27(9):1187-95. PubMed ID: 18046223
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: results of the Pan-american Collaborative Retina Study Group at 24 months.
Arevalo JF; Lasave AF; Wu L; Diaz-Llopis M; Gallego-Pinazo R; Alezzandrini AA; Berrocal MH;
Retina; 2013 Feb; 33(2):403-13. PubMed ID: 23222389
[TBL] [Abstract][Full Text] [Related]
8. Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema.
Soheilian M; Garfami KH; Ramezani A; Yaseri M; Peyman GA
Retina; 2012 Feb; 32(2):314-21. PubMed ID: 22234244
[TBL] [Abstract][Full Text] [Related]
9. Update on nonsurgical therapy for diabetic macular edema.
Witkin AJ; Brown GC
Curr Opin Ophthalmol; 2011 May; 22(3):185-9. PubMed ID: 21427573
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.
Solaiman KA; Diab MM; Abo-Elenin M
Retina; 2010; 30(10):1638-45. PubMed ID: 20838357
[TBL] [Abstract][Full Text] [Related]
11. Repeated intravitreal bevacizumab injection with and without macular grid photocoagulation for treatment of diffuse diabetic macular edema.
Solaiman KA; Diab MM; Dabour SA
Retina; 2013 Sep; 33(8):1623-9. PubMed ID: 23538584
[TBL] [Abstract][Full Text] [Related]
12. Diabetic macular edema: changing treatment paradigms.
Arevalo JF
Curr Opin Ophthalmol; 2014 Nov; 25(6):502-7. PubMed ID: 25211039
[TBL] [Abstract][Full Text] [Related]
13. Management paradigms for diabetic macular edema.
Mitchell P; Wong TY;
Am J Ophthalmol; 2014 Mar; 157(3):505-13.e1-8. PubMed ID: 24269850
[TBL] [Abstract][Full Text] [Related]
14. Patient-reported visual function outcomes improve after ranibizumab treatment in patients with vision impairment due to diabetic macular edema: randomized clinical trial.
Mitchell P; Bressler N; Tolley K; Gallagher M; Petrillo J; Ferreira A; Wood R; Bandello F;
JAMA Ophthalmol; 2013 Oct; 131(10):1339-47. PubMed ID: 23974915
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.
Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Liu DT; Li KK; Li PS; Shanmugam MP
Ophthalmology; 2007 Dec; 114(12):2162-7. PubMed ID: 17459479
[TBL] [Abstract][Full Text] [Related]
16. Initial macular thickness and response to treatment in diabetic macular edema.
Soheilian M; Ramezani A; Yaseri M; Mirdehghan SA; Obudi A; Bijanzadeh B
Retina; 2011 Sep; 31(8):1564-73. PubMed ID: 21451442
[TBL] [Abstract][Full Text] [Related]
17. Comparison of grid laser, intravitreal triamcinolone, and intravitreal bevacizumab in the treatment of diffuse diabetic macular edema.
Sobaci G; Ozge G; Erdurman C; Durukan HA; Bayraktar ZM
Ophthalmologica; 2012; 227(2):95-9. PubMed ID: 21893972
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal injections and diabetic macular edema: actual and new therapeutic options.
Pescosolido N; Pranno F; Buomprisco G
Curr Diabetes Rev; 2013 Nov; 9(6):491-8. PubMed ID: 24160355
[TBL] [Abstract][Full Text] [Related]
19. Upcoming therapeutic advances in diabetic macular edema: an intravitreal dexamethasone drug delivery system.
Augustin AJ
Expert Opin Drug Deliv; 2011 Feb; 8(2):271-9. PubMed ID: 21222552
[TBL] [Abstract][Full Text] [Related]
20. [Intravitreal triamcinolone combined with grid laser photocoagulation for patients with cystoid macular edema and advanced diabetic retinopathy: pilot study].
Arévalo JF; Fernández CF; Mendoza AJ; García RA; Arévalo FA
Arch Soc Esp Oftalmol; 2013 Oct; 88(10):373-9. PubMed ID: 24060300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
